Use And Effect Of Raktamitraka In Pandu Roga (ANAEMIA)

Phase 2

Not yet recruiting

• Conditions: Anemia, unspecified. Ayurveda Condition: PANDUROGAH,

• Registration Number: CTRI/2024/04/065844
• Lead Sponsor: MMM Goverment Ayurveda College Udaipur

Brief Summary

This study is A Comparative Pharmaceutico -  Analytical Study And Clinical Efficacy of Raktamitrarka W.S.R. To Pandu Roga ( Anaemia). There will be 2 groups in the study, In Group A randomly selected and clinically diagnosed 30 patients of Pandu roga whose Hb gm % will be of 06 to 10 gm % .  Group A will be given Raktamitrarka prepared as per classical method and 30 patients of Group B randomly selected and clinically diagnosed will be given Raktamitrarka prepared by contemporary method.

Trial will be conduct for a period of 2 months. Follow up of the case will be after every 15 days that is 4 times during treatment. Final assessment will be done after completion of 2 months course on the basis of subjective, objective and laboratoral assessment.

The data will be analyzed  scientifically and statistically.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2024-03-28
• Study Start: 2024-05-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Sign and symptoms of Anaemia.
• Evidence of Anaemia by lab investigations.
• Participates in age group of 18-70 years.
• Patients with Anaemia between 06gm %-10gm % of Haemoglobin.

Exclusion Criteria

• Patients suffered with serious cardiac disorders like MI, Cardiac failure and Crisis Patients having life threatening disease.
• Patient having major illness like IDDM, DM which is poorly controlled or newly diagnosed or is taking new therapy or recently adjusted therapy.
• Patient having Carcinoma.
• Pregnant lady.
• Patient with severe Anaemia below 06 gm% of Haemoglobin.
• Patient suffering with Thalassemia, Bone marrow disorders, autoimmune disorders and Iron toxicity.
• Patient himself or herself wants to withdraw from the clinical trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Quantity of Haemoglobin	60 days

Secondary Outcome Measures

Name	Time	Method
Anemia scale will be assessed	15 days,30 days & 45 days

Trial Locations

Locations (1)

MMM Govt. Ayurveda College Udaipur; 🇮🇳 Udaipur, RAJASTHAN, India

MMM Govt. Ayurveda College Udaipur

🇮🇳Udaipur, RAJASTHAN, India

Dr Sandeep

Principal investigator

7073523228

Sandeepmahla3228@gmail.com